The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Quality of Life in Brain Tumor Patients: The Relative Contributions of Depression, Fatigue, Emotional Distress, and Existential Issues
Abstract
Neuropsychiatric problems, and how they interact to impact on quality of life (QOL) in brain tumor patients, are generally poorly understood. The objectives of this study were: (1) to document the prevalence of depression, fatigue, emotional distress, and existential issues in a sample of brain tumor patients (2) to examine the interconnectedness of these problems, and (3) to explore their relationship with disease-related variables and QOL. This is a cross-sectional, questionnaire-based survey of 73 patients with primary brain tumors who presented to a neurological clinic at a tertiary cancer centre for ongoing care. Data for 60 participants (29 women, 31 men) who completed validated questionnaires were retained for analysis. Results showed that there was a high burden of depressive symptoms as measured by the Beck Depression Inventory-II (mean score 11.1, SD 7.4), with 38% of the sample scoring in the clinically depressed range. Overall QOL scores for this sample were similar to a reference sample of brain tumor patients. The scores on the existential subscale of the McGill Quality of Life questionnaire were comparable to those of a reference sample of cancer patients receiving ongoing care (mean score 7.2; SD 1.7). Fifty per cent of the sample could be classified as struggling with existential issues. Although scores reflecting depression, fatigue, emotional distress, and existential problems were interrelated, the presence of depressive symptoms was the single most import…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Estimates of existential distress among terminal cancer patients range from 3% to 29%, depending on how the concept is defined.
“prevalence rates of existential distress in patients with terminal cancer vary from 3 to 29%, depending on the operationalization of the concept”
From Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review (2022) · cites this paper as Pelletier et al., 2002
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,842
Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)
Hu, R. J. (2003) · Elsevier eBooks · doi:10.1016/b0-12-226870-9/01070-4 · Cited by 9,168
The functional assessment of cancer therapy scale: development and validation of the general measure
Cella, D. F., Tulsky, D. S., Gray, G., Sarafian, B., Linn, E., Bonomi, A., Silberman, M., Yellen, S. B., Winicour, P., & Brannon, J. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.570 · Cited by 6,020
The psychology of religion and coping : theory, research, practice
Pargament, K. (1998) · Review of Religious Research · doi:10.2307/3512468 · Cited by 1,680
The Psychology of Religion and Coping
Mcfadden, S., & Pargament, K. (1997) · Journal for the Scientific Study of Religion · doi:10.2307/1387534 · Cited by 1,597
Decision making during serious illness: What role do patients really want to play?
Degner, L. F., & Sloan, J. A. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90110-9 · Cited by 1,012
Cohen, S. R., Mount, B. M., Strobel, M. G., & Bui, F. (1995) · Palliative Medicine · doi:10.1177/026921639500900306 · Cited by 737
Psychometric evaluation of the Beck Depression Inventory-II with primary care medical patients.
Arnau, R. C., Meagher, M. W., Norris, M. P., & Bramson, R. (2001) · Health Psychology · doi:10.1037/0278-6133.20.2.112 · Cited by 694
Psychometric evaluation of the Beck Depression Inventory-II with primary care medical patients.
Arnau, R. C., Meagher, M. W., Norris, M. P., & Bramson, R. (2001) · Health Psychology · doi:10.1037//0278-6133.20.2.112 · Cited by 692
Comorbid depression and anxiety spectrum disorders
Gorman, J. M. (1996) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1996)4:4 · Cited by 629
Cohen, S. R., Mount, B. M., Bruera, E. D., Provost, M., Rowe, J., & Tong, K. L. (1997) · Palliative Medicine · doi:10.1177/026921639701100102 · Cited by 437
Mayer, A., Takimoto, M., Fritz, E., Schellander, G., Kofler, K., & Ludwig, H. (1993) · Cancer · doi:10.1002/1097-0142(19930415)71:8 · Cited by 407
Methylphenidate therapy improves cognition, mood, and function of brain tumor patients.
Meyers, C. A., Weitzner, M. A., Valentine, A. D., & Levin, V. A. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.7.2522 · Cited by 377
Osoba, D., Aaronson, N. K., Muller, M. J., Sneeuw, K. C. A., Hsu, M.-A., Yung, W. K. A., Brada, M., & Newlands, E. S. (1996) · Quality of Life Research · doi:10.1007/bf00435979 · Cited by 343
Fehring, R. J., Miller, J. F., & Shaw, C. (1997) · PubMed · Cited by 322
TAPHOORN, M. J. B., Schiphorst, A. K., Snoek, F. J., Lindeboom, J., Wolbers, J. G., Karim, A. B. M. F., Huijgens, P. C., & Heimans, J. J. (1994) · Annals of Neurology · doi:10.1002/ana.410360111 · Cited by 302
Cotton, S. P., Levine, E. G., Fitzpatrick, C. M., Dold, K. H., & Targ, E. (1999) · Psycho-Oncology · doi:10.1002/(sici)1099-1611(199909/10)8:5 · Cited by 278
Kiebert, G. M., Curran, D., Aaronson, N. K., Bolla, M., Menten, J. J., Rutten, E. H. J. M., Nordman, E., Silvestre, M. E., Piérart, M., & Karim, A. B. M. F. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00268-8 · Cited by 256
Spiritual Well‐Being, Religiousness and Hope Among Women With Breast Cancer
Mickley, J. R., Soeken, K. L., & Belcher, A. E. (1992) · Journal of Nursing Scholarship · doi:10.1111/j.1547-5069.1992.tb00732.x · Cited by 216
Spiritual Well-Being and Anxiety in Adults Diagnosed with Cancer
Kaczorowski, J. M. (1989) · The Hospice Journal · doi:10.1080/0742-969x.1989.11882658 · Cited by 197
Anxiety and depression in patients with an intracranial neoplasm before and after tumour surgery
PRINGLE, A.-M., TAYLOR, R., & Whittle, I. R. (1999) · British Journal of Neurosurgery · doi:10.1080/02688699944177 · Cited by 166
Neuropsychiatric aspects of traumatic brain injury
Arciniegas, D. B., Topkoff, J. L., & Silver, J. (2000) · Current Treatment Options in Neurology · doi:10.1007/s11940-000-0017-y · Cited by 164
Mackworth, N., Fobair, P., & Prados, M. (1992) · Journal of Neuro-Oncology · doi:10.1007/bf00172600 · Cited by 152
Psychological management of post‐stroke depression
Kneebone, I. I., & Dunmore, E. (2000) · British Journal of Clinical Psychology · doi:10.1348/014466500163103 · Cited by 127 · cited 1×
“Our knowledge of the effectiveness of psychotherapy for depression in brain tumor patients or other neurologically impaired populations remains limited, but cognitive behavior therapy has been identified as worthy of additional investigation [43,44].”
BackgroundArmstrong, C. L., Ruffer, J. E., Corn, B. W., DeVries, K., & Mollman, J. E. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.9.2263 · Cited by 124
Quality of life in HIV disease as measured by the McGill Quality of Life Questionnaire
Cohen, S. R., Hassan, S. A., Lapointe, B. J., & Mount, B. M. (1996) · AIDS · doi:10.1097/00002030-199610000-00016 · Cited by 124
Somnolence syndrome in adults following cranial irradiation for primary brain tumours
Faithfull, S., & Brada, M. (1998) · Clinical Oncology · doi:10.1016/s0936-6555(98)80011-3 · Cited by 112
Boyd, J. A., Takahashi, H., Waggoner, S. E., Jones, L. A., Hajek, R. A., Wharton, J. T., Liu, F.-S., Fujino, T., Barrett, J. C., & McLachlan, J. A. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960201)77:3 · Cited by 103
Relationship between fatigue and quality of life in patients with glioblastoma multiformae.
Lovely, M., Miaskowski, C., & Dodd, M. J. (1999) · PubMed · Cited by 99
Quality of life in brain tumor patients
Gıovagnolı, A. R., Tamburini, M., & Boiardi, A. (1996) · Journal of Neuro-Oncology · doi:10.1007/bf00177445 · Cited by 93
Psychosocial and Neuropsychiatric Aspects of Patients with Primary Brain Tumors
Weitzner, M. A. (1999) · Cancer Investigation · doi:10.3109/07357909909040599 · Cited by 90
Alternative therapy use in neurologic diseases
Verhoef, M. J., Hagen, N. A., Pelletier, G., & Forsyth, P. A. (1999) · Neurology · doi:10.1212/wnl.52.3.617 · Cited by 80
Self-citationRecording neurological impairment in clinical trials of glioma
Grant, R., Slattery, J. M. A., Gregor, A., & Whittle, I. R. (1994) · Journal of Neuro-Oncology · doi:10.1007/bf01051047 · Cited by 62
Brain Tumor as a Threat to Life and Personality
Salander, P. (1996) · Journal of Psychosocial Oncology · doi:10.1300/j077v14n03_01 · Cited by 61
Brain tumor support group: content themes and mechanisms of support.
Leavitt, M., Lamb, S. A., & Voss, B. S. (1996) · PubMed · Cited by 49
The severity of major depression and choice of treatment in primary care practice.
Schulberg, H. C., Pilkonis, P. A., & Houck, P. R. (1998) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.66.6.932 · Cited by 36
Relationships: importance for patients with cerebral tumours
Kaplan, M. E. M. C. P. (2000) · Brain Injury · doi:10.1080/026990500120727 · Cited by 35
Quality of life of brain tumor patients
Lovely, M. (1998) · Seminars in Oncology Nursing · doi:10.1016/s0749-2081(98)80045-4 · Cited by 34
Quality-of-life issues in patients with malignant gliomas.
Aiken, R. D. (1994) · PubMed · Cited by 32
THE ROLE OF PSYCHOTHERAPY IN TREATING PSYCHIATRIC DISORDERS
Craighead, W. E., & Craighead, L. W. (2001) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70332-1 · Cited by 29
Community Integration Questionnaire for Patients with Brain Tumor
Kaplan, C. P. (2000) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/00002060-200005000-00005 · Cited by 18
Shinoda, J., Sakai, N., Hara, A., et al. (1997) · Journal of Neuro-Oncology · doi:10.1023/a:1005816320920 · Cited by 13
Psychiatric and Psychosocial Aspects of Neurooncology
Passik, S. D., Malkin, M. G., BREITBART, W. S., et al. (1994) · Journal of Psychosocial Oncology · doi:10.1300/j077v12n01_06 · Cited by 12
Parchi, P., Giese, A., Capellari, S., Brown, P., Schulz-Schaeffer, W., Windl, O., Zerr, I., Budka, H., Kopp, N., Piccardo, P., et al. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199908)46:2
Holland (1999) · doi:10.1002/(sici)1099-1611(199901/02)8:1
Flagged first, then by citations
Research works printed but not linked: 4
- Beck A, Steer RA, Brown GK: Manual for the Beck Depression Inventory-II. The Psychological Corporation, New York, 1996
- Craighead WE, Craighead L, Ilardi SS: Psychosocial treatments for major depressive disorder. In: Nathan PE, Gorman JM (eds) A Guide to Treatments that Work. Oxford University Press, New York, 1998, pp 226-239
- Simpson S: Management of depression in cancer patients. Perspectives in Depression 8: 1-5, 2000
- Cole B, Pargament K: Re-creating your life: a spiritual/ psychotherapeutic intervention for people diagnosed with cancer. Psychooncology 8: 395-407, 1999 · DOI
Cited by
Sorted by citations
Incidence of Suicide in Persons With Cancer
Misono, S., Weiss, N. S., Fann, J. R., Redman, M., & Yueh, B. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.8941 · Cited by 608
Psychiatric disorders in advanced cancer
Miovic, M., & Block, S. (2007) · Cancer · doi:10.1002/cncr.22980 · Cited by 376
Czarny, P., Wigner, P., Galecki, P., & Sliwinski, T. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.06.036 · Cited by 310
Treatment of existential distress in life threatening illness: A review of manualized interventions
LeMay, K., & Wilson, K. G. (2008) · Clinical Psychology Review · doi:10.1016/j.cpr.2007.07.013 · Cited by 280
Patient suffering and caregiver compassion: new opportunities for research, practice, and policy.
Schulz, R., Hebert, R. S., Dew, M. A., Brown, S. L., Scheier, M. F., Beach, S. R., Czaja, S. J., Martire, L. M., Coon, D., Langa, K. M., et al. (2007) · The Gerontologist · doi:10.1093/geront/47.1.4 · Cited by 163
Schimmers, N., Breeksema, J. J., Smith-Apeldoorn, S. Y., Veraart, J., van den Brink, W., & Schoevers, R. A. (2022) · Psychopharmacology · doi:10.1007/s00213-021-06027-y · Cited by 162
Linking What We Eat to Our Mood: A Review of Diet, Dietary Antioxidants, and Depression
Huang, Q., Liu, H., Suzuki, K., Ma, S., & Liu, C. (2019) · Antioxidants · doi:10.3390/antiox8090376 · Cited by 144
Coyne, J. C., Palmer, S. C., Shapiro, P. J., Thompson, R., & DeMichele, A. (2004) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2003.08.012 · Cited by 123
Milbury, K., Weathers, S.-P., Durrani, S., Li, Y., Whisenant, M., Li, J., Lim, B., Weinberg, J. S., Kesler, S. R., Cohen, L., et al. (2020) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2020.02.004 · Cited by 68
Fear of cancer recurrence and death anxiety: unaddressed concerns for adult neuro-oncology patients
Loughan, A. R., Lanoye, A., Aslanzadeh, F. J., Villanueva, A. A. L., Boutte, R., Husain, M., & Braun, S. (2021) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-019-09690-8 · Cited by 60
Papuć, E., & Stelmasiak, Z. (2012) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2011.11.012 · Cited by 58
Bauwens, S., Baillon, C., Distelmans, W., & Theuns, P. (2009) · Psycho-Oncology · doi:10.1002/pon.1425 · Cited by 54
Bauwens, S., Baillon, C., Distelmans, W., & Theuns, P. (2014) · Psycho-Oncology · doi:10.1002/pon.3484 · Cited by 47
Loughan, A. R., Willis, K. D., Braun, S. E., Rodin, G., Lanoye, A., Davies, A. E., Svikis, D., Mazzeo, S., Malkin, M., & Thacker, L. (2022) · Journal of Neuro-Oncology · doi:10.1007/s11060-022-03988-8 · Cited by 29
Szpringer, M., Oledzka, M., & Amann, B. L. (2018) · Frontiers in Psychology · doi:10.3389/fpsyg.2018.00785 · Cited by 22
Rimmer, B., Dutton, L., Lewis, J., Burns, R., Gallagher, P., Williams, S., Araujo-Soares, V., Finch, T., & Sharp, L. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-041465 · Cited by 12
Metadata
- Authors
- Pelletier, G., Verhoef, M. J., Khatri, N., & Hagen, N.
- Affiliations
- University of Calgary (CA)
- ORCID
- Hagen, Neil
- Venue
- Journal of Neuro-Oncology
- Published
- 2002-03
- Volume
- 57
- Issue
- 1
- Pages
- 41-49
- ISSN
- 0167-594X (ISSN-L)
- 1573-7373
- OpenAlex
- W1574260815
- Cited by
- 362
- References
- 49
- Citations by year
- 2026: 8 · 2025: 2 · 2024: 17 · 2023: 9 · 2022: 18 · 2021: 13 · 2020: 23 · 2019: 16 · 2018: 26 · 2017: 24 · 2016: 21 · 2015: 28 · 2014: 12 · 2013: 19 · 2012: 20
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Journal of Neuro-Oncology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Owens Foundation
- Topics
- Health Sciences › Medicine › Oncology › Cancer survivorship and care
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Childhood Cancer Survivors' Quality of Life
- Keywords
- quality of life, brain tumors, depression, fatigue, emotional distress, existential questions, neuropsychiatric symptoms, primary brain tumors, prevalence of depressive symptoms, McGill Quality of Life Questionnaire, predictors of quality of life
- MeSH terms
- Adult, Affective Symptoms, Brain Neoplasms, Depression, Fatigue, Female, Humans, Male, Middle Aged, Quality of Life, Surveys and Questionnaires, Regression Analysis, Prevalence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
